News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,407 Results
Type
Article (40613)
Company Profile (297)
Press Release (666497)
Multimedia
Podcasts (74)
Webinars (12)
Section
Business (207064)
Career Advice (2071)
Deals (35872)
Drug Delivery (100)
Drug Development (82380)
Employer Resources (176)
FDA (16250)
Job Trends (15168)
News (350072)
Policy (32862)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2574)
Accelerated approval (5)
Adcomms (20)
Allergies (83)
Alliances (50221)
ALS (89)
Alzheimer's disease (1397)
Antibody-drug conjugate (ADC) (127)
Approvals (16247)
Artificial intelligence (248)
Autoimmune disease (21)
Automation (16)
Bankruptcy (363)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (107)
Biotechnology (212)
Bladder cancer (64)
Brain cancer (27)
Breast cancer (273)
Cancer (2155)
Cardiovascular disease (175)
Career advice (1727)
Career pathing (33)
CAR-T (146)
Cell therapy (413)
Cervical cancer (19)
Clinical research (66951)
Collaboration (827)
Compensation (525)
Complete response letters (21)
COVID-19 (2609)
CRISPR (37)
C-suite (236)
Cystic fibrosis (101)
Data (2104)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (263)
Diagnostics (6374)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (119)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87444)
Editorial (41)
Employer branding (23)
Employer resources (150)
Events (114480)
Executive appointments (719)
FDA (17463)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (738)
Gene editing (102)
Generative AI (20)
Gene therapy (292)
GLP-1 (732)
Government (4457)
Grass and pollen (5)
Guidances (51)
Healthcare (18896)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (111)
Indications (29)
Infectious disease (2749)
Inflammatory bowel disease (135)
Inflation Reduction Act (9)
Influenza (50)
Intellectual property (93)
Interviews (328)
IPO (16736)
IRA (41)
Job creations (3836)
Job search strategy (1469)
Kidney cancer (10)
Labor market (38)
Layoffs (478)
Leadership (20)
Legal (7958)
Liver cancer (72)
Lung cancer (310)
Lymphoma (146)
Machine learning (5)
Management (58)
Manufacturing (299)
MASH (68)
Medical device (13370)
Medtech (13375)
Mergers & acquisitions (19668)
Metabolic disorders (683)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (29)
Neuroscience (1923)
NextGen: Class of 2025 (6571)
Non-profit (4496)
Northern California (2589)
Now hiring (40)
Obesity (367)
Opinion (221)
Ovarian cancer (74)
Pain (82)
Pancreatic cancer (80)
Parkinson's disease (148)
Partnered (21)
Patents (229)
Patient recruitment (105)
Peanut (46)
People (58110)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20887)
Phase II (29543)
Phase III (21900)
Pipeline (1139)
Policy (144)
Postmarket research (2573)
Preclinical (8830)
Press Release (64)
Prostate cancer (101)
Psychedelics (31)
Radiopharmaceuticals (255)
Rare diseases (375)
Real estate (6030)
Recruiting (67)
Regulatory (22486)
Reports (46)
Research institute (2342)
Resumes & cover letters (354)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (68)
Series A (127)
Series B (82)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2228)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3657)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (35)
The Weekly (46)
United States (22617)
Vaccines (689)
Venture capitalists (42)
Weight loss (240)
Women's health (38)
Worklife (19)
Date
Today (180)
Last 7 days (534)
Last 30 days (2522)
Last 365 days (33273)
2025 (9839)
2024 (35731)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35386)
2017 (32636)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (741)
Alabama (57)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (39095)
Australia (6319)
California (5929)
Canada (1970)
China (518)
Colorado (262)
Connecticut (268)
Delaware (140)
Europe (84358)
Florida (883)
Georgia (202)
Idaho (57)
Illinois (522)
India (25)
Indiana (308)
Iowa (10)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (882)
Massachusetts (4460)
Michigan (216)
Minnesota (385)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1694)
New Mexico (29)
New York (1696)
North Carolina (1004)
North Dakota (7)
Northern California (2589)
Ohio (200)
Oklahoma (14)
Oregon (35)
Pennsylvania (1329)
Puerto Rico (12)
Rhode Island (32)
South America (1121)
South Carolina (21)
South Dakota (1)
Southern California (2228)
Tennessee (101)
Texas (887)
Utah (175)
Virginia (143)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (52)
707,407 Results for "sutro biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Sutro Cuts Half of Staff, Deprioritizes ADC in Strategic Review
Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate luveltamab tazevibulin, which it was studying for ovarian cancer. The biotech will seek licensing opportunities for the asset.
March 14, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
March 14, 2025
·
7 min read
Press Releases
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
March 4, 2025
·
1 min read
Press Releases
Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline
March 14, 2025
·
8 min read
Business
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc. has entered into a strategic partnership with Sutro Biopharma, Inc. to support clinical production of luveltamab tazevibulin, abbreviated as “luvelta”, a novel Folate Receptor-α -targeting antibody-drug conjugate with the potential to address the unmet need in several FRα-expressing cancers.
June 3, 2024
·
4 min read
Press Releases
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
March 17, 2025
·
5 min read
Press Releases
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
Business
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today reported its financial results for the first quarter of 2024, its recent business highlights, and a preview of select anticipated milestones.
May 13, 2024
·
10 min read
Press Releases
Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale
January 8, 2025
·
6 min read
1 of 70,741
Next
